Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
33%
Ph early_phase_1
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Not yet recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
not_yet_recruiting267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Keverprazan Combined With Amoxicillin for the Treatment of Helicobacter Pylori

NCT06851468
not_yet_recruitingearly_phase_1

The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication

NCT06777732
not_yet_recruitingphase_4

Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori

NCT06412640

Clinical Trials (3)

Showing 3 of 3 trials
NCT06851468Not Applicable

Keverprazan Combined With Amoxicillin for the Treatment of Helicobacter Pylori

Completed
NCT06777732Early Phase 1

The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication

Not Yet Recruiting
NCT06412640Phase 4

Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3